The civic record
Read. Follow. Verify.Congressional Hearing on Tuberculosis in Southern Africa
Record date · January 1, 2018
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
This hearing transcript documents a 2018 Congressional subcommittee meeting focused on the high mortality rates of tuberculosis in Southern Africa. Experts from the CDC, State Department, and USAID provided testimony on the challenges of diagnosing and treating the disease, particularly in populations with HIV.
The hearing examines the effectiveness of U.S. global health funding and strategies in addressing the world's deadliest infectious disease, which disproportionately impacts Southern Africa.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Sub-Saharan African populations
These populations experience higher rates of tuberculosis infection and mortality compared to other global regions.
U.S. Centers for Disease Control and Prevention (CDC)
The agency provides expertise and data to inform U.S. global health policy and intervention strategies.
USAID
The agency is responsible for implementing global health programs and distributing aid related to tuberculosis treatment.
Key Facts
- Tuberculosis was the deadliest infectious disease in the world in 2016, causing 1.7 million deaths.
- In 2016, 44 percent of all global tuberculosis deaths occurred in the Africa region.
- The Africa region accounted for 25 percent of all new tuberculosis cases in 2016.
- The tuberculosis death rate in Africa is 72 per 100,000 infected, compared to 35 in Southeast Asia and 13 in the eastern Mediterranean.
Show all 8 facts
- Nearly 75 percent of people co-infected with HIV and tuberculosis in 2016 lived in sub-Saharan Africa.
- Tuberculosis is curable if patients are diagnosed and follow a proper treatment regimen.
- Millions of newly infected people go undiagnosed and untreated annually.
- Multiple drug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis strains are emerging due to inappropriate or incomplete treatment.
Frequently Asked Questions
Why is tuberculosis considered a major global health threat?
Why is Southern Africa specifically highlighted?
What makes tuberculosis harder to treat in some cases?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Focus on Drug-Resistant Strains
The hearing highlights a shift in concern toward drug-resistant strains (MDR/XDR) resulting from incomplete treatment regimens.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools